GLP-1 may slow biological aging
A new study provides the first clinical evidence that popular semaglutide drugs, like Ozempic or Wegovy, could slow down processes associated with biological aging.
Summary
Recent research indicates that semaglutide drugs, commonly known for weight loss, might also have the potential to slow biological aging. This finding could reshape the understanding of these medications beyond their current uses.
Comments (182 of ) ⌛